Literature DB >> 25290399

Strategies for cell-mediated immunotherapy of cancer: killing or help?

G Forni1, M Giovarelli.   

Abstract

Entities:  

Year:  1986        PMID： 25290399     DOI： 10.1016/0167-5699(86)90104-0

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  5 in total

Review 1.  Immunotherapy I: Cyclosine gene transfer strategies.

Authors:  M P Colombo; G Forni
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

2.  Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation.

Authors:  H Schild; P von Hoegen; V Schirrmacher
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Augmentation of cell number and LAK activity in peripheral blood mononuclear cells activated with anti-CD3 and interleukin-2. Preliminary results in children with acute lymphocytic leukemia and neuroblastoma.

Authors:  P M Anderson; F H Bach; A C Ochoa
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. Phenotypic and functional analysis of the peripheral blood mononuclear cells.

Authors:  C Fortis; E Ferrero; C Besana; M Biffi; S Heltai; L Galli; A Borri; A Schoenheit; C Rugarli
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 5.  Strategies for cytokine utilisation in tumor therapy.

Authors:  F Di Pierro; F Cavallo; F Pericle; S Bertini; M Giovarelli; G Forni
Journal:  Med Oncol Tumor Pharmacother       Date:  1993
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.